| Persistence with asthma treatment is low in Germany especially for controller medication - a population based study of 483,051 patients. | |
| | |
MedLine Citation:
|
PMID: 19712117 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The objective of the present analysis was to evaluate treatment patterns and persistence with treatment of an unselected patient population with a diagnosis of asthma. METHODS: The database of the Bavarian statutory health insurance physician's association (Kassenärztliche Vereinigung) covering 83% of the population was analyzed for an index period from April 2005 to March 2006. Defined daily doses (DDDs) were used to quantify treatment persistence. Results were compared with recent guidelines. RESULTS: The prevalence of physician diagnosed asthma in Bavaria was 4.8% in females and 4.5% in males; only 61.4% of these patients (of a total of n = 483,051) received any anti-asthmatic pharmacotherapy; 68.3% received medical care from their general practitioner, and 8.3% from a pulmonologist alone. Most patients (65.1%) received no more than 90 DDDs of controller medication in the index period of 365 days, only about 1% received medication for the complete index period. Long- (40.1%) and short-acting beta(2)-agonists (65.6%) were used more frequently than inhaled corticosteroids (ICS). 52.8% of asthma patients were treated in accordance with guidelines. CONCLUSIONS: Persistence of asthma patients with medical treatment is low, especially for controller medication. The discrepancy between current knowledge, guidelines and clinical practice is substantial and may question the value of current guidelines for the treatment of patients with asthma in ambulatory care. In addition, the results of this study cast doubt on the impact of contemporary treatment on the decline of asthma mortality seen in recent years in Germany. |
| | |
Authors:
|
J Hasford; J Uricher; M Tauscher; P Bramlage; J C Virchow |
Related Documents
:
|
6152937 - Ltua--a new and more reproducible method of estimating intrauterine size. 18412527 - Suspected albuterol toxicosis in a dog. 11901787 - Cough syrup addiction and rampant caries: a report of two cases. 20671137 - Asthma, asthma medications, and prostate cancer risk. 20508997 - Don't get spooked! how to collaborate with a professional medical communicator (and avo... 17803337 - Reliability of medicaid claims versus medical record data: in a cost analysis of palivi... |
Publication Detail:
|
Type: Journal Article Date: 2009-08-27 |
Journal Detail:
|
Title: Allergy Volume: 65 ISSN: 1398-9995 ISO Abbreviation: Allergy Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-04-27 Completed Date: 2010-08-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7804028 Medline TA: Allergy Country: Denmark |
Other Details:
|
Languages: eng Pagination: 347-54 Citation Subset: IM |
Affiliation:
|
Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, University of Munich, Munich, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Inhalation Adrenal Cortex Hormones / administration & dosage Adrenergic beta-Agonists / administration & dosage Adult Anti-Asthmatic Agents / administration & dosage* Asthma / drug therapy*, epidemiology Female Germany Guideline Adherence* Guidelines as Topic Humans Male Physician's Practice Patterns* Prevalence Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Adrenal Cortex Hormones; 0/Adrenergic beta-Agonists; 0/Anti-Asthmatic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus.
Next Document: The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1?